Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Kozo Sonoda is active.

Publication


Featured researches published by Kozo Sonoda.


International Journal of Cancer | 1998

Proliferative activity of cancer cells in front and center areas of carcinoma in situ and invasive sites of esophageal squamous‐cell carcinoma

Hiroyuki Kuwano; Hiroshi Saeki; Hidetoshi Kawaguchi; Kozo Sonoda; Kaoru Kitamura; Hideaki Nakashima; Yasushi Toh; Keizo Sugimachi

Intraepithelial carcinoma contiguous with invasive squamous‐cell carcinoma is a conspicuous feature of esophageal cancer. However, whether the mechanism of intraepithelial spreading is due to cell proliferation or field carcinogenesis has yet to be clarified. This study investigated the mechanism of intraepithelial spreading by measuring the cell proliferative activity using argyrophilic nucleolar organizer region (AgNOR) and proliferating cell nuclear antigen (PCNA)‐positive cell counting. We examined the AgNOR number and PCNA‐positive ratio (PCNA ratio) in the center and outer edge of intraepithelial carcinoma and in the center and deep margin of invasive squamous‐cell carcinoma of the esophagus in 50 specimens from 18 cases of esophageal squamous‐cell carcinoma concomitant with contiguous intraepithelial carcinoma. The proliferative activity was thus found to differ between the normal epithelium and cancerous lesions (p < 0.001), between intraepithelial carcinoma and invasive cancer (p < 0.001) and between deep margin and center areas of invasive cancer (p < 0.005). On the other hand, such activity was observed to be similar in the center and outer edge of the intraepithelial spread. These findings suggest that cell proliferation is the main mechanism of tumor progression at the invasive site of cancer, whereas in intraepithelial carcinomatous areas, “field carcinogenesis” or a paracrine mechanism, and not cell proliferation, is thought to be the cause of intraepithelial spread of esophageal cancer. These results therefore support the concept of field carcinogenesis. Int. J. Cancer 78:149–152, 1998.© 1998 Wiley‐Liss, Inc.


Cancer | 1996

What is the earliest malignant lesion in the esophagus

Kaoru Kitamura; Hiroyuki Kuwano; Mitsuhiro Yasuda; Kozo Sonoda; Kohei Sumiyoshi; Shinichi Tsutsui; Masayuki Kitamura; Keizo Sugimachi

The incidence of early esophageal cancer is definitely increasing due to recent advances in diagnostics. When we discuss early carcinoma of the esophagus, however, there is still controversy as to whether dysplasia is either benign or the earliest malignant lesion.


Journal of Surgical Oncology | 1997

Tumor invasion and angiogenesis in early esophageal squamous cell carcinoma.

Hiroyuki Kuwano; Kozo Sonoda; Mitsuhiro Yasuda; Kohei Sumiyoshi; Tadahiro Nozoe; Keizo Sugimachi

Although the relationship between angiogenesis and tumor proliferation or malignant potential has been previously demonstrated in several studies, early stage of cancer invasion and angiogenesis has seldom been investigated.


International Journal of Hyperthermia | 1998

Relationship between the expression of HLA-DR antigen and the effectiveness of preoperative hyperthermo-chemo-radiotherapy in oesophageal cancer

Hiroyuki Kuwano; Hidehisa Saeki; Hidetoshi Kawaguchi; Kozo Sonoda; Kaoru Kitamura; Hiroshi Nakashima; Yasushi Toh; Keizo Sugimachi

Based on the hypothesis that tumour cells expressing HLA-DR antigen would easily be damaged by the local immune response during preoperative treatments, the relationship was investigated between the expression of HLA-DR antigen in the oesophageal cancer and the effectiveness of the preoperative treatment. Immunohistochemical staining for the detection of HLA-DR antigen in cancer cells from biopsy specimens obtained before undergoing preoperative hyperthermo-chemo-radiotherapy (HCR therapy) in patients with oesophageal squamous cell carcinoma was performed, and the relationship between the expression of HLA-DR antigen and the effectiveness of HCR therapy was evaluated according to a histopathologic examination of resected specimen. A total of 35 cases were examined in which 14 showed strongly positive staining (+2), 14 weakly positive staining (+) and seven negative staining (-). No significant differences in the clinicopathologic factors between the groups were observed. In the 14 strongly positive HLA-DR antigen cases, nine were markedly effective (grade 3) (64.3%), four were moderately effective (grade 2) (28.6%) and one was slightly effective or ineffective (grade 1, 0) (7.1%). In the 14 weakly positive HLA-DR antigen cases, the markedly, moderately and slightly or ineffective cases numbered four (28.6%), eight (57.1%) and two (14.3%), respectively. On the other hand, in the seven patients showing no HLA-DR expression, the markedly, moderately and slightly effective cases numbered one (14.3%), two (28.6%) and four (57.1%), respectively. A statistical difference was observed between the cases of strongly positive and negative staining for HLA-DR antigen (p < 0.05). The expression of HLA-DR antigen in oesophageal cancer cells is thus considered to potentially be a valuable factor for predicting the effectiveness of preoperative treatment.


Surgery Today | 1998

Abdominal incisional hernia occurring after an esophagectomy reconstructed with a gastric tube through an antesternal route: Report of a case

Hiroshi Saeki; Hiroyuki Kuwano; Hidetoshi Kawaguchi; Kozo Sonoda; Takefumi Ohga; Kaoru Kitamura; Hideaki Nakashima; Yasushi Toh; Keizo Sugimachi; Toshio Oiwa

A Japanese man, who had undergone a subtotal esophagectomy reconstructed with a gastric tube through an antesternal route for esophageal carcinoma 16 years previously, was admitted to our hospital because of an abdominal incisional hernia. The abdominal incisional hernia was in his upper abdomen and was difficult to push back into the intraabdominal cavity by hand. The hernia was successfully repaired by operation. We thus conclude that an abdominal incisional hernia is a rare but important late-phase complication occurring after an esophagectomy reconstructed with either an antesternal or retrosternal route, and an operation should be the treatment of choice.


Clinical Cancer Research | 1998

Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.

Kozo Sonoda; Tsunehisa Kaku; Toshiharu Kamura; Manabu Nakashima; Takeshi Watanabe; Hitoo Nakano


International Journal of Oncology | 1995

Establishment of a new human uterine cervical adenocarcinoma cell-line, siso, and its reactivity to anticancer reagents.

Kozo Sonoda; Manabu Nakashima; Toshiaki Saito; Satoshi Amada; Toshiharu Kamura; Hitoo Nakano; Takeshi Watanabe


Hepato-gastroenterology | 1996

Prognostic significance of immunological parameters in patients with esophageal cancer

Shinichi Tsutsui; Kozo Sonoda; Kohei Sumiyoshi; Kaoru Kitamura; Yasushi Toh; Masayuki Kitamura; Hiroyuki Kuwano; Keizo Sugimachi; Seiichi Okamura


Hepato-gastroenterology | 2001

Pathogenesis of esophageal squamous cell carcinoma with lymphoid stroma.

Hiroyuki Kuwano; Kohei Sumiyoshi; Kozo Sonoda; Kaoru Kitamura; Yasushi Toh; Hideaki Nakashima; Keizo Sugimachi


Hepato-gastroenterology | 1997

Expression of p53 protein in glandular differentiation admixed with squamous cell carcinoma of the esophagus.

Hiroyuki Kuwano; Kohei Sumiyoshi; Kozo Sonoda; Kaoru Kitamura; Shinichi Tsutsui; Yasushi Toh; Masayuki Kitamura; Keizo Sugimachi

Collaboration


Dive into the Kozo Sonoda's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge